Search results
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoPrevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...
Humira: the highs and lows of the world’s best-selling drug
Pharmaceutical Technology via Yahoo Finance· 6 days agoHumira, an arthritis medication with indications for colitis and psoriasis is the world’s...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 5 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Integrated Advisors Network LLC
ETF DAILY NEWS· 4 days agoIntegrated Advisors Network LLC decreased its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 28.9% during the 4th quarter, according to its most recent disclosure with the SEC. The firm ...
175 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Livelsberger Financial Advisory
ETF DAILY NEWS· 6 days agoLivelsberger Financial Advisory purchased a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The ...
First Financial Bank Trust Division Has $345,000 Position in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 5 days agoFirst Financial Bank Trust Division lowered its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.2% during the first quarter, according to the company in its most recent Form 13F filing ...
Check Out What Whales Are Doing With AMGN - Amgen (NASDAQ:AMGN)
Benzinga· 6 days agoFlagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced ...
Trust Co. of Toledo NA OH Has $428,000 Stake in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 4 days agoTrust Co. of Toledo NA OH decreased its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 33.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities ...
Gateway - Quartz
Quartz· 6 days agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative drug in history. Since entering the market in 2003, it has made its manufacturer an estimated ...
Livelsberger Financial Advisory Invests $26,000 in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 6 days agoLivelsberger Financial Advisory purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) during the fourth quarter, according to the company in its most recent disclosure ...
